- Home
- MIST vs VATE Comparison
MIST vs VATE Comparison
Compare MIST & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- VATE
- Stock Information
- Founded
- MIST 2003
- VATE 1994
- Country
- MIST Canada
- VATE United States
- Employees
- MIST N/A
- VATE 4024
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- MIST Health Care
- VATE Industrials
- Exchange
- MIST Nasdaq
- VATE Nasdaq
- Market Cap
- MIST 81.5M
- VATE 82.6M
- IPO Year
- MIST N/A
- VATE 1996
- Fundamental
- Price
- MIST $1.43
- VATE $6.10
- Analyst Decision
- MIST Strong Buy
- VATE
- Analyst Count
- MIST 3
- VATE 0
- Target Price
- MIST $13.00
- VATE N/A
- AVG Volume (30 Days)
- MIST 177.8K
- VATE 50.3K
- Earning Date
- MIST 11-11-2024
- VATE 11-06-2024
- Dividend Yield
- MIST N/A
- VATE N/A
- EPS Growth
- MIST N/A
- VATE N/A
- EPS
- MIST N/A
- VATE N/A
- Revenue
- MIST N/A
- VATE $1,364,600,000.00
- Revenue This Year
- MIST N/A
- VATE N/A
- Revenue Next Year
- MIST N/A
- VATE N/A
- P/E Ratio
- MIST N/A
- VATE N/A
- Revenue Growth
- MIST N/A
- VATE N/A
- 52 Week Low
- MIST $1.12
- VATE $3.25
- 52 Week High
- MIST $3.52
- VATE $14.60
- Technical
- Relative Strength Index (RSI)
- MIST 42.50
- VATE 71.67
- Support Level
- MIST $1.41
- VATE $6.18
- Resistance Level
- MIST $1.53
- VATE $6.49
- Average True Range (ATR)
- MIST 0.07
- VATE 0.43
- MACD
- MIST -0.01
- VATE 0.05
- Stochastic Oscillator
- MIST 26.96
- VATE 86.72
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.